Company: EFU Life Assurance Ltd | Ticker: EFUL | Reporting period: six months and three months ended June 30, 2026 | Basis: unaudited company-level life-insurance financial statements; the cumulative six-month figures were subject to a limited-scope review, while the separate three-month figures were not reviewed.
Verdict: EFU Life produced strong premium growth and a much better second quarter, but the quality of that growth was mixed. Gross premium expanded 21.3%, yet the fastest growth came from single-premium, corporate-benefits and family-takaful business rather than the slower-growing regular individual base. H1 profit after tax rose 6.0% even though profit before tax fell 4.0%, because lower tax expense offset weaker investment returns and adverse fair-value movements. The quarter therefore looks better than the half-year trend, and the next cycle should be read through premium mix, investment volatility, regulatory capital and the large disputed sales-tax exposure—not headline profit alone.
Results at a glance
The exact identity, period, figures and board actions are traceable to EFU Life’s official H1 2026 report and the PSX financial-results filing. The statements cover EFU Life Assurance Limited’s statutory funds at company level; they are not consolidated group accounts.
- Gross premium and contribution rose to Rs31.81 billion from Rs26.23 billion, an increase of 21.3%.
- Net premium increased 23.8% to Rs29.74 billion as ceded premium declined to Rs2.07 billion from Rs2.22 billion.
- Investment income fell 13.2% to Rs13.35 billion, while the half-year moved to a net unrealized fair-value loss of Rs974 million from a gain of Rs1.05 billion.
- Profit before tax declined 4.0% to Rs1.884 billion, but profit after tax rose 6.0% to Rs1.289 billion because tax expense fell 20.2%.
- H1 EPS was Rs12.28 versus Rs11.59. Q2 EPS was Rs8.52 versus Rs5.46, reflecting a 56.0% rise in second-quarter profit after tax to Rs894.6 million.
- Total assets rose 2.0% from December 2025 to Rs303.98 billion; insurance liabilities increased 2.2% to Rs283.72 billion.
- The board declared an interim cash dividend of Rs1.50 per share for the quarter.
- After period end, EFU Life proposed 45 million right shares at Rs10 each, increasing the pre-issue share count by 42.86% and raising Rs450 million if fully subscribed.
AlphaGen model outputs
These four readings are AlphaGen model outputs, not company-reported figures. Unavailable readings are disclosed without estimation.
- Alpha QoQ Score: Unavailable
- TTM Performance Score: Unavailable
- 3Y Business Perf Score: 49.77
- Sector Leadership Score: 48.52
What improved
The clearest operating improvement was premium momentum. Gross premium rose faster than the comparable half, and net premium grew faster still because reinsurance cessions declined. That combination increased the premium retained by EFU Life, although retained premium is not the same thing as immediate profit: benefits, acquisition costs, liability movements and investment returns determine how much value emerges.
The second quarter also repaired much of the market damage recorded in the first quarter. EFU Life reported an unrealized fair-value gain of Rs12.63 billion in Q2 after a Rs13.60 billion loss in Q1. That reversal helped Q2 net income rise 63.4% to Rs34.77 billion and supported a 22.9% increase in quarterly profit before tax. The improvement was real in the reported accounts, but it was market-sensitive and largely non-cash.
Underwriting cash flow was less negative: the half-year underwriting outflow narrowed to Rs5.07 billion from Rs6.47 billion. Total operating cash outflow also improved to Rs6.31 billion from Rs7.98 billion. For an insurer, these figures must be read together with investment purchases and sales because premiums are invested to meet future policyholder obligations.
What weakened / needs attention
The half-year investment engine weakened. Investment income fell by about Rs2.04 billion, and the fair-value line deteriorated by roughly Rs2.08 billion year on year. The Q2 rebound did not fully erase the first-quarter loss, leaving H1 with a Rs974 million unrealized loss. This is why the stronger quarterly profit should not be treated as a clean run rate.
Core cost growth also mattered. Net insurance benefits rose 10.9% to Rs26.03 billion, acquisition expenses increased 10.5% to Rs5.68 billion, and marketing and administration expenses rose to about Rs2.98 billion from Rs2.15 billion. Premium growth absorbed these pressures, but the expense base is scaling faster than the slower-growing regular retail premium pool.
The limited-scope review draws attention to a provincial sales-tax dispute. EFU Life had not recognized a claimed liability of Rs11.08 billion at June 2026, up from Rs9.56 billion at December 2025, relying on legal advice described in the report. The reviewer did not modify its conclusion, but the amount is larger than the company’s Rs10.17 billion equity base. This is a disputed contingency, not a booked loss; its legal and regulatory progress is nevertheless material.
Premium growth was strong, but mix explains the economics
Premium composition shows why the 21.3% headline needs qualification. New individual regular premium, including takaful, rose only 3.8% to Rs2.84 billion, and renewal premium increased about 1.6% to Rs12.4 billion. By contrast, single premium more than tripled to Rs3.57 billion, corporate-benefits life premium rose 51.9% to Rs8.37 billion, and total family-takaful contribution increased 31.1% to Rs7.72 billion.
Regular individual policies normally provide the clearest view of franchise depth because new sales can generate future renewals and because renewal persistence reveals whether customers stay. Single-premium and corporate-benefits flows can add scale quickly, but may be more episodic or mandate-driven. AlphaGen’s inference is therefore that EFU Life’s current volume growth is broad enough to matter, yet not all of it should be annualized at the same quality.
Health premium grew only 4.2% to Rs5.05 billion, while takaful health contribution rose 2.2%. That slower pace contrasts with corporate life and individual takaful. The mix shift can affect acquisition cost, claims behavior, reinsurance use and the duration of liabilities, so future disclosures should be judged segment by segment rather than by a single premium total.
Investment income, liability movements and the earnings bridge
Life-insurance earnings combine underwriting flows with investment returns on assets backing long-duration obligations. EFU Life’s portfolio remained dominated by government securities, which increased 5.6% from December to Rs194.37 billion. Term deposits fell to Rs734 million from Rs3.37 billion; equity securities were Rs66.66 billion, slightly below December. The shift increases exposure to government-security yields and valuation while reducing the term-deposit balance.
Reported net income rose only 2.9% for H1 despite 23.8% net-premium growth because investment income declined and fair-value movements turned negative. Net insurance benefits increased, while the net change in insurance liabilities fell to Rs5.32 billion from Rs8.03 billion for the half. In Q2 alone that liability movement was much larger, at Rs15.93 billion, absorbing much of the quarter’s fair-value rebound. This is normal insurance accounting logic: market gains on assets cannot be read without the related movement in policyholder obligations.
The tax line completed the bridge to profit after tax. PBT was lower, but tax expense fell from Rs745 million to Rs595 million. The resulting 6.0% PAT increase is therefore not evidence that every pre-tax earnings driver improved. For the next result, the cleaner test is whether regular premium, investment income and expense growth support pre-tax profit before another favorable tax comparison.
Balance sheet, liquidity and cash conversion
Assets expanded to Rs303.98 billion and liabilities to Rs293.81 billion, leaving equity almost flat at Rs10.17 billion. Cash and bank balances fell to Rs4.99 billion from Rs5.87 billion. Investment activities generated Rs4.20 billion of cash, well below Rs10.19 billion in the comparable half, while financing outflow was Rs1.40 billion. Overall cash and cash equivalents fell by Rs3.52 billion to Rs5.72 billion.
This is not industrial-company cash conversion. An insurer can show accounting profit while buying securities, paying claims and increasing policy liabilities; those activities are part of asset-liability management rather than simply working-capital consumption. The relevant questions are whether cash and liquid investments cover near-term claims, whether asset duration and currency match obligations, and whether capital remains sufficient after dividends and growth.
Capital expenditure was modest at Rs262 million, close to Rs238 million a year earlier. The business is therefore not plant-intensive. Its capital intensity lies instead in solvency requirements, distribution investment, technology, claims infrastructure and the assets required to back policyholder liabilities.
Recurring versus exceptional drivers
- More recurring: renewal premium, regular new-business volumes, policy persistence, acquisition efficiency, claims experience, operating expenses and returns earned on the fixed-income book.
- Recurring but mix-sensitive: corporate-benefits, health and takaful growth. These can persist, but pricing, mandate renewal and claims experience may vary by contract.
- More episodic: the 212% increase in single premium and the 51.9% rise in corporate-benefits life premium should not be extrapolated without evidence of repeat mandates.
- Market-driven and volatile: Q2’s Rs12.63 billion unrealized gain reversed most of Q1’s Rs13.60 billion loss. It improved reported earnings but is not a stable operating run rate.
- Below the pre-tax line: the 20.2% fall in tax expense enabled PAT growth despite lower PBT. The benefit may not repeat.
- Post-period capital action: the rights issue raises paid-up capital and share count; it is not H1 operating income.
Dividend and the rights-capital reset
The board action is recorded on the PSX company page. The Rs1.50-per-share interim dividend distributes cash, while the right issue brings in up to Rs450 million at par. The official offer document says the issue is intended to meet revised minimum-capital requirements, strengthen solvency and support growth.
The mechanics matter for per-share analysis. Share count would rise from 105 million to 150 million, a 42.86% increase, while the offer document shows total equity increasing only 4.42% on its pre/post illustration. Future EPS comparisons will therefore need the applicable weighted-average share count and any required restatement. The capital raise improves nominal paid-up capital, but the more important business test is whether it supports durable premium growth and solvency without weakening returns on the larger share base.
What changed from Q1 to Q2
EFU Life’s official first-quarter report showed how market conditions dominated early 2026: Q1 carried the Rs13.60 billion unrealized loss and profit after tax of Rs394.8 million. Q2 then delivered the Rs12.63 billion unrealized gain and Rs894.6 million profit after tax. The half-year result is the net of those very different quarters.
This pattern is the central analytical lesson. EFU Life’s insurance franchise continued to collect premium in both periods, but short-term reported earnings were shaped by asset valuations and policy-liability accounting. Investors and policyholders should distinguish franchise indicators—new regular premium, renewals, takaful growth and claims—from fair-value noise and tax timing.
Key risks and accounting transition
The largest disclosed company-specific risk is the unresolved provincial sales-tax matter. Market and interest-rate movements are the next major variable because government securities and equities form most of the investment book. Premium mix, lapse behavior, claims inflation, reinsurance costs and acquisition spending can also change the economics of new business.
A major reporting transition is approaching. The H1 report says IFRS 17 and IFRS 9 are applicable for periods beginning January 1, 2027 under the relevant SECP direction, and implementation work is in progress. The SECP insurance licensing and capital framework is also relevant to the capital raise. IFRS 17 will change how insurance service results and liabilities are measured and presented, so 2027 comparatives may look materially different even if the underlying policies do not change.
What to monitor next
- Regular new-business premium and renewal growth: these are better franchise indicators than one-off single-premium spikes.
- Persistence and claims experience by life, health and takaful lines, where available.
- Investment income and the split between realized and unrealized gains or losses, alongside the movement in insurance liabilities.
- Acquisition, marketing and administration expense growth relative to net premium.
- Cash and liquid investments, solvency disclosures and completion of the 45-million-share rights issue.
- Any legal or regulatory development on the Rs11.08 billion provincial sales-tax claim.
- Management’s IFRS 17 and IFRS 9 implementation disclosures ahead of January 2027 adoption.
Sources and methodology
Primary figures, review status and accounting notes come from EFU Life’s H1 2026 report, cross-checked to the PSX result filing and the company’s financial-report archive. Q1-to-Q2 analysis uses the official Q1 report, and capital-action analysis uses the official right-issue offer document.
The source sweep also checked the PACRA June 2026 life-insurance research listing and Adamjee Life’s official financial-information page as sector and peer context. These secondary checks do not override EFU Life’s filings. Percentage changes are AlphaGen calculations from publicly reported comparative figures; causal interpretation is identified as inference where management did not provide a direct explanation. This article is analytical reporting, not investment advice.